Evidence map›Paper›PMID 26986823›Full record

ArticleHuman gene therapy2016

Allele-Specific Quantitative PCR for Accurate, Rapid, and Cost-Effective Genotyping.

Han B Lee, Tanya L Schwab, Alaa Koleilat, Hirotaka Ata, Camden L Daby, Roberto Lopez Cervera, Melissa S McNulty, Hannah S Bostwick, Karl J Clark

Abstract read
In one paragraph

Article in Human gene therapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Intergenic Variants Upstream of GADD45b Affect Survival ofInternational journal of molecular sciences · 2025
    Article
  2. An Assay for Variable Fragment Length Allele-Specific Genotyping.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  3. Article
  4. Article
  5. A Fusion of Taq DNA Polymerase with the CL7 Protein fromMolecules (Basel, Switzerland) · 2024
    Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Han B Lee1 Neurobiology of Disease Graduate Program, Mayo Graduate School , Rochester, Minnesota.
Tanya L Schwab2 Department of Biochemistry and Molecular Biology, Mayo Clinic , Rochester, Minnesota.
Alaa Koleilat3 Clinical and Translational Science Graduate Program, Mayo Graduate School , Rochester, Minnesota.
Hirotaka Ata3 Clinical and Translational Science Graduate Program, Mayo Graduate School , Rochester, Minnesota.
Camden L Daby2 Department of Biochemistry and Molecular Biology, Mayo Clinic , Rochester, Minnesota.
Roberto Lopez Cervera2 Department of Biochemistry and Molecular Biology, Mayo Clinic , Rochester, Minnesota.
Melissa S McNulty2 Department of Biochemistry and Molecular Biology, Mayo Clinic , Rochester, Minnesota.
Hannah S Bostwick2 Department of Biochemistry and Molecular Biology, Mayo Clinic , Rochester, Minnesota.
Karl J Clark1 Neurobiology of Disease Graduate Program, Mayo Graduate School , Rochester, Minnesota.

Funding

PILOT AND FEASIBILTY PROGRAMP30DK084567 · NIDDK · MAYO CLINIC ROCHESTER · PI GREGORY J. GORES · 2009 to 2026
$22.2M
Systematic Vertebrate Functional GenomicsR01GM063904 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI EKKER, STEPHEN CARL · 2001 to 2025
$10.7M
Developing zebrafish models to reveal interactions between stress and addictionR21DA032194 · NIDA · MAYO CLINIC ROCHESTER · PI CLARK, KARL J · 2011 to 2012
$394k
NIDA NIH HHS R21 DA032194NIDDK NIH HHS P30 DK084567NIGMS NIH HHS R01 GM063904
6 · The paper itself

Abstract

Customizable endonucleases such as transcription activator-like effector nucleases (TALENs) and clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9 (CRISPR/Cas9) enable rapid generation of mutant strains at genomic loci of interest in animal models and cell lines. With the accelerated pace of generating mutant alleles, genotyping has become a rate-limiting step to understanding the effects of genetic perturbation. Unless mutated alleles result in distinct morphological phenotypes, mutant strains need to be genotyped using standard methods in molecular biology. Classic restriction fragment length polymorphism (RFLP) or sequencing is labor-intensive and expensive. Although simpler than RFLP, current versions of allele-specific PCR may still require post-polymerase chain reaction (PCR) handling such as sequencing, or they are more expensive if allele-specific fluorescent probes are used. Commercial genotyping solutions can take weeks from assay design to result, and are often more expensive than assembling reactions in-house. Key components of commercial assay systems are often proprietary, which limits further customization. Therefore, we developed a one-step open-source genotyping method based on quantitative PCR. The allele-specific qPCR (ASQ) does not require post-PCR processing and can genotype germline mutants through either threshold cycle (Ct) or end-point fluorescence reading. ASQ utilizes allele-specific primers, a locus-specific reverse primer, universal fluorescent probes and quenchers, and hot start DNA polymerase. Individual laboratories can further optimize this open-source system as we completely disclose the sequences, reagents, and thermal cycling protocol. We have tested the ASQ protocol to genotype alleles in five different genes. ASQ showed a 98-100% concordance in genotype scoring with RFLP or Sanger sequencing outcomes. ASQ is time-saving because a single qPCR without post-PCR handling suffices to score genotypes. ASQ is cost-effective because universal fluorescent probes negate the necessity of designing expensive probes for each locus.

Indexed as

AllelesAnimalsCost-Benefit AnalysisDNA PrimersGenotypePolymerase Chain ReactionSequence Analysis, DNAZebrafishZebrafish ProteinsDNA PrimersZebrafish Proteins

Identifiers

PMID26986823
PMCPMC4931339

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.